ABSSSI Therapeutics Market
As per the DelveInsight, the ABSSSI pipeline appears quite active with several emerging candidates in Phase III and Phase II stages of development, with many more in the early stages of development. At present, the key pharmaceutical companies including Innovation Pharmaceuticals, MotifBio, Basilea Pharmaceutica, Debiopharm, Destiny Pharma, KBP Biosciences, MicuRx Pharmaceuticals, and several ot..